Impaired Arsenic Methylation and Proteomic Alterations in Skin Cancer
Overview
Chronic exposure to inorganic arsenic (iAs) leads to significant proteomic changes in human keratinocytes. This study highlights the impaired arsenic methylation process in keratinocytes.
Background
Inorganic arsenic is a well-known carcinogen affecting millions globally, with skin being the most common target organ for arsenic-induced malignancies. The study of human keratinocytes exposed to iAs provides insights into the transformation processes leading to cutaneous squamous cell carcinoma.
Data Highlights
No numerical or trial data provided in the source material.
Key Findings
Chronic exposure to iAsIII transforms non-malignant HaCaT cells into an aggressive cSCC-like phenotype.
HaCaT cells do not methylate iAsIII, suggesting that iAsIII itself drives malignant transformation.
Proteomic changes during iAsIII-induced malignant transformation remain largely unexplored.
Arsenic methylation status may influence keratinocyte transformation.
Understanding the role of arsenic metabolites is essential for identifying targets in arsenic-induced carcinogenesis.
Clinical Implications
Clinicians should consider the implications of arsenic exposure in patients, particularly in regions with high environmental arsenic levels.
Conclusion
Further research is needed to clarify the role of arsenic methylation in skin carcinogenesis.
by Alexandra N. Nail, Mayukh Banerjee, Manting Xu, Caitlin H. Reynolds, Miroslav Stýblo, Peter H. Cable, Daniel W. Wilkey, Michael L. Merchant, Ana P. Ferragut Cardoso, Shelia D. Thomas, J. Christopher States
